Tracking blood flow in the eye during treatment for diabetic eye disease
Monitoring the hemodynamic response to therapy in diabetic retinopathy
This study is looking at how blood flow in the eye changes during treatment for diabetic retinopathy, so doctors can find better ways to help people with diabetes keep their vision healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10661730 on NIH RePORTER |
What this research studies
This research investigates how blood flow in the retina changes during treatments for diabetic retinopathy using non-invasive imaging techniques. By monitoring these changes, the study aims to develop new measurement tools that can help doctors better manage and treat patients facing serious vision complications from diabetes. The approach focuses on understanding the physiological responses to therapy, which could lead to improved patient outcomes. Patients will be monitored throughout their treatment to gather data on retinal blood flow and its implications for vision health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with diabetic retinopathy who are undergoing medical treatment.
Not a fit: Patients without diabetic retinopathy or those not receiving treatment for this condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new tools for doctors to prevent vision loss in patients with diabetic retinopathy.
How similar studies have performed: Other research has shown promise in using non-invasive imaging techniques to monitor eye conditions, suggesting that this approach could be effective.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Fawzi, Amani a — Northwestern University at Chicago
- Study coordinator: Fawzi, Amani a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.